For citations:

Kolyadina I.V. Trastuzumab deruxtecan in the treatment of patients with advanced breast cancer with HER2-low expression: Recent studies review. Tumors of female reproductive system. 2023;19(3):63-76. (In Russ.) https://doi.org/10.17650/1994-4098-2023-19-3-63-76